JPRN-jRCT1031220145尚未招募4 期
A pilot study of switching from multipe nucleot(s)ide analogues to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatits B virus infection
MOCHIDA Satoshi0 个研究点目标入组 20 人开始时间: 2022年6月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients with chronic HBV infection receiving multipe nucleot(s)ide analogues such as ETV plus TAF or LAM plus TAF
排除标准
- •Patients who do not consent with clinical trial
研究者
相似试验
已完成
不适用
The study for usefulness of switching nucleoside/nucleotide analogues (NAs) to tenofovir alafenamide fumarate in patients with chronic HBV infection treated with other NAschronic HBV infectionJPRN-UMIN000030661Saitama Medical University70
招募中
不适用
Effect of switching therapy from nucleos(t)ide analogue to pegylated-interferon in patients with chronic hepatitis Bchronic hepatitis BJPRN-UMIN000012415Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine200
尚未招募
不适用
Prospective study for the usefulness of single nucleotide polymorphism of immune related genes as a predictive factor of nivolumab effect for the patients with advanced non-small cell lung canceron-small cell lung carcinomaJPRN-UMIN000033411Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University112
进行中（未招募）
1 期
Controlled Interruption of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B InfectionsEUCTR2021-001003-32-BEAntwerp University Hospital140
招募中
1 期
Investigator-initiated phase 1 study of nucleic acid medicine targeting PRDM14 in patients with breast cancerbreast cancerJPRN-jRCT2031190181Takahashi Shunji12